» Articles » PMID: 23025428

A Study of Incidence of AKI in Critically Ill Patients

Overview
Journal Ren Fail
Publisher Informa Healthcare
Date 2012 Oct 3
PMID 23025428
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There have been many studies to estimate the incidence of acute kidney injury (AKI) in critically ill patients. However, results were variable due to the non-usage of uniform criteria and retrospective design of most studies. There are no new studies from the developing countries looking at AKI in these patients since adoption of uniform Acute Kidney Injury Network (AKIN) criteria.

Methods: In this prospective observational study from a tertiary care hospital in India, we enrolled 100 consecutively admitted critically ill patients and followed them during hospital stay. AKI was defined by AKIN criteria. Both the groups of patients, those who developed AKI and those who did not develop AKI, were then followed during the course of their hospital stay.

Results: AKI occurred in 33 patients with an incidence rate of 17.3 per person year. Thirty-one out of 33 (93.9%) patients died in the AKI group, whereas 31 out of 67 (53.7%) patients died in the non-AKI group. Independent risk factors for AKI were older age (adjusted relative risk (RR) = 4.42, 95% CI = 2.57-5.23), septic shock (adjusted RR = 2.82, 95% CI = 1.43-3.80), prolonged duration of mechanical ventilation (adjusted RR = 2.35, 95% CI = 1.09-3.6), higher acute physiology and chronic health evaluation II (APACHE II) score (adjusted RR = 2.74, 95% CI = 1.28-4.13), and higher sequential organ failure assessment (SOFA) score (adjusted RR = 2.53, 95% CI = 1.04-4.08). Development of AKI was an independent risk factor for mortality (adjusted RR = 1.76, 95% CI = 1.25-1.84).

Conclusion: Older patients, those with septic shock, and those requiring prolonged mechanical ventilation had increased risk for AKI. AKI was an independent predictor of mortality.

Citing Articles

The Impact of Continuous Veno-Venous Hemodiafiltration on the Efficacy of Administration of Prophylactic Doses of Enoxaparin: A Prospective Observational Study.

Aszkielowicz A, Steckiewicz K, Okragly M, Wujtewicz M, Owczuk R Pharmaceuticals (Basel). 2023; 16(8).

PMID: 37631081 PMC: 10457944. DOI: 10.3390/ph16081166.


The incidence, risk factors and prognosis of acute kidney injury in severe and critically ill patients with COVID-19 in mainland China: a retrospective study.

Sang L, Chen S, Zheng X, Guan W, Zhang Z, Liang W BMC Pulm Med. 2020; 20(1):290.

PMID: 33167955 PMC: 7649893. DOI: 10.1186/s12890-020-01305-5.


Epidemiology and Pathogenesis of Acute Kidney Injury in the Critically Ill Patients.

Kulkarni A, Bhosale S Indian J Crit Care Med. 2020; 24(Suppl 3):S84-S89.

PMID: 32704209 PMC: 7347066. DOI: 10.5005/jp-journals-10071-23394.


The utility of neutrophil gelatinase-associated Lipocalin (NGAL) as a marker of acute kidney injury (AKI) in critically ill patients.

Khawaja S, Jafri L, Siddiqui I, Hashmi M, Ghani F Biomark Res. 2019; 7:4.

PMID: 30834123 PMC: 6387517. DOI: 10.1186/s40364-019-0155-1.


Association between chloride-rich versus chloride-restrictive intravenous fluid administration and acute kidney injury in cardiovascular patients in ICU wards.

Wang X, Zhang C, Huang G, Han D, Meng X, Guo Y Exp Ther Med. 2016; 12(2):987-990.

PMID: 27446309 PMC: 4950183. DOI: 10.3892/etm.2016.3431.